InvestorsHub Logo
Followers 4
Posts 658
Boards Moderated 0
Alias Born 05/31/2016

Re: None

Thursday, 02/16/2017 10:56:16 AM

Thursday, February 16, 2017 10:56:16 AM

Post# of 20617
Once again, you can't compare to those pharma who has phase 1 & 2 trials lined up.... Innv is more of a retail. We all know there is no jackpot. Fluticare can bring some.. but $15m a year is still a peanut for investors.. i agree the current price has been unfair.. but no news no buy......even with the fluticare approval, this will only go .30?? max for now... there is a saying sell the news!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.